Published on 28/11/2025

Storyboards for PAT/Model Changes

In the highly regulated pharmaceutical industry, implementing changes to processes, materials, or controls can trigger a need for thorough validation to ensure compliance with stringent standards set forth by regulatory bodies such as the US FDA, EMA, MHRA, and PIC/S. Storyboards play a critical role in structuring these changes, particularly when it comes to Process Analytical Technology (PAT) and model changes. This article serves as a comprehensive guide for pharmaceutical professionals on how to effectively utilize storyboards in change control impact assessments, focusing on verification versus re-validation, bridging studies, and periodic reviews.

Understanding the Framework of Change Control

Change control is defined as a systematic approach to managing all changes made to a product or system. The key objectives of change control include ensuring that the integrity of the final product is not compromised and that any modifications are compliant with regulatory requirements. A well-structured change control process not only mitigates risks but also provides a robust rationale for any alterations made in processes or equipment.

In pharmaceutical manufacturing, changes may arise from equipment upgrades, process improvements, or variations in packaging materials. The necessity to reassess and validate processes due to these changes mandates an understanding of the differences between verification versus re-validation.

Verification vs Re-Validation

Verification is generally conducted to confirm that the system operates as intended and meets predetermined requirements. It encompasses activities such as installation qualification (IQ) and operational qualification (OQ), validating that the modifications are properly implemented and functioning within expected parameters.

Re-validation, in contrast, is a more extensive process applied when considerable changes occur that may affect product quality, safety, or efficacy. Activities involved in re-validation might include:

• Re-evaluation of original validation documentation.
• Creation of new verification protocols.
• Conducting bridging studies to establish equivalence between old and new systems.
• Updating evidence packs that present data to justify results.

Understanding when to utilize verification and when to implement re-validation hinges on the specific nature and risk level associated with the change. A thorough change control impact assessment can guide this decision-making process.

Developing Storyboards for Effective Change Control Impact Assessment

Storyboards serve as visual guides to assist teams in tracking the changes and their implications throughout the validation process. Creating effective storyboards should be done in a systematic step-by-step approach:

Step 1: Identify the Change

Begin by clearly documenting the details of the change. This includes identifying what the change is, the reason behind it, and its expected impact on the product or process. Every change should undergo a rigorous risk-based analysis to understand its potential effect on product quality.

Step 2: Conduct a Risk-Based Change Impact Assessment

A risk-based change impact assessment is critical to determining whether verification or re-validation is required. Utilize tools such as Failure Mode and Effects Analysis (FMEA) to evaluate potential risks associated with the change. This analysis should focus on:

• Identifying critical process parameters (CPPs) that might be affected.
• Assessing how these changes correlate with analogs and historical data.
• Defining risk thresholds and prevailing cpv limits.

The successful outcome of this assessment will lend credence to the continued ability of the process to generate a product that meets quality specifications post-modification.

Step 3: Prepare Evidence Packs

Once the risk assessment is complete, the next step is to prepare evidence packs. Evidence packs are comprehensive documents compiled to support decision-making and verification efforts. They should include:

• Validation protocols and conclusions.
• Results of any bridging studies conducted.
• Data relating to the effectiveness checks and how they compare to previous iterations.
• Documentation supporting adherence to compliance standards, including references to 21 CFR Part 211.

Sharing these packs with relevant stakeholders ensures transparency and facilitates informed decision-making during the change control process.

Implementing Changes through Bridging Studies

When any significant changes occur, including modifications in the raw materials or packaging, it is prudent to conduct bridging studies. Bridging studies are essential to establish the validity of the proposed changes and demonstrate equivalence with previous product iterations.

Key Considerations for Bridging Studies

When planning bridging studies, the following considerations are paramount:

• Define the objectives of the study clearly. What hypotheses are you testing?
• Determine the appropriate statistical methods and study designs suited to validate the change.
• Incorporate previous validation data to validate new datasets adequately.
• Ensure compliance with standards outlined in Annex 15 to guarantee robustness of the study.

Results from the bridging study will provide the evidence necessary to assess whether the revised processes yield output consistent with the established quality outcomes.

Adjustment of Sampling Plan Updates and Periodic Review Processes

Implementing a change in a process often necessitates an update of the sampling plan to ensure representativeness and regulatory compliance. A thorough adjustment of the sampling plan can ensure ongoing conformity to established quality levels while also addressing potential shifts in product characteristics.

Updating Sampling Plans

When updating sampling plans, it is essential to:

• Evaluate the sampling frequency and sizes to reflect the potential variability introduced by the change.
• Consider the correlation between sampling and the new process’s quality attributes.
• Document adjustments transparently to maintain a clear audit trail.

Efficiently updating the sampling plan ensures that the quality control processes remain robust and that any discrepancies can be identified and addressed with swift remedial action.

Executing Periodic Reviews

Periodic reviews are indispensable in ensuring ongoing compliance and effectiveness of validated processes. Regular assessments allow teams to:

• Review performance metrics of the modified processes.
• Update documentation and validation protocols as required.
• Assess Lessons Learned from these changes, feeding them back into the Quality Management System (QMS).

The strategy for periodic reviews should be built into the quality management framework and align with the overall compliance requirements from regulatory authorities such as the EMA and MHRA.

Conclusion

In conclusion, navigating through PAT/model changes requires a rigorous methodology characterized by detailed documentation, effective risk assessment, and robust verification processes. By employing storyboards as visual tools throughout the change control lifecycle, professionals can enhance the clarity and effectiveness of impact assessments, bridging studies, and validation efforts, ensuring continuous compliance with regulatory standards.

For effective implementation, it is vital to remain vigilant about updates in regulatory expectations and to incorporate Lessons Learned from previous experiences into future change efforts. Through diligence and adherence to best practices, pharmaceutical organizations can maintain the integrity of their processes and quality of their products, ultimately achieving a greater commitment to patient health and safety.